Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 723 of 6351
-
CAR t therapy takes on lupus, MS, and more in first human safety trial
Disease control Recruiting nowA Phase 1 study of HBI0101 BCMA-CART in B-Cell Mediated Autoimmune Rheumatic Diseases. The goal of the study is evaluation of safety and identification of the maximum HBI0101 CART dose that may be administered safely to patients with B-cell mediated autoimmune disease.
Phase 1 • Sponsor: Polina Stepensky • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a common supplement boost cancer therapy? new trial tests taurine with immunotherapy for stomach cancer.
Disease control Recruiting nowThis project aims to evaluate the efficacy and safety of oral taurine supplementation combined with PD-1 inhibitor (serplulimab) and chemotherapy in inducing systemic CD8+ T cell responses and achieving improved gastric cancer patient outcomes than with serplulimab and chemothera…
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
A drug that boosts platelets may speed recovery after stem cell transplants in kids with thalassemia
Disease control CompletedThe objective of this observational study is to investigate the long-term effects of Hetrombopag in promoting platelet engraftment during haploidentical hematopoietic stem cell transplantation (HSCT) in children with thalassemia, with a specific focus on a 28-day time window post…
Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a nebulized cocktail make lung scopes less Cough-Inducing?
Symptom relief CompletedThe current study is looked for the comparison between nebulized lidocaine and ketamine, nebulized lidocaine, and usual lidocaine spray in the oral and nasal cavities before flexible bronchoscopy. The investigators are looking for different outcomes including mainly cough suppres…
Phase 4 • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Can a VR headset beat numbing cream for Children's needle pain?
Symptom relief Recruiting nowThis randomized controlled trial evaluates methods to reduce pain during venipuncture in children aged 3 to 15 years. The study compares three approaches: virtual reality distraction using a VR headset, topical anesthesia with EMLA cream, and standard care without an additional p…
Sponsor: Marie Lulková • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Which blood thinner combo best prevents a second stroke?
Disease control Recruiting nowAlong with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel minor stroke or TIA compared to 300 mg clopidogrel were assessed through NIHSS, mRS, and possible adverse effects.
Phase 3 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 26, 2026 13:49 UTC
-
A carpal tunnel clue to a silent heart threat?
Knowledge-focused Recruiting nowPatients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed…
Sponsor: Helse Møre og Romsdal HF • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can AI help surgeons see thyroid cancer more clearly?
Diagnosis CompletedThis prospective, single-center, single-arm study evaluates a locked artificial intelligence (AI) system as a surgeon-led second-read tool before thyroid surgery. Eligible participants scheduled for thyroid surgery undergo standard ultrasonography followed by a standardized AI-as…
Sponsor: Fujian Medical University • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New combo therapy shows promise for untreatable liver cancer
Disease control OngoingThe goal of this clinical trial is to evaluate whether sequential transarterial chemoembolization (TACE) followed by stereotactic body radiotherapy (SBRT) combined with targeted immunotherapy is effective and safe for patients with intermediate to advanced hepatocellular carcinom…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Cholesterol drug may block melanoma spread in High-Risk patients
Prevention OngoingThis clinical trial tests whether atorvastatin prevents metastasis of resected high-risk stage IIA, IIB or IIIA melanoma. The vast majority of melanomas are diagnosed at an early, localized stage. However, approximately 10-15% of these localized melanomas will eventually metastas…
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Could a heart drug help immunotherapy fight breast cancer again?
Disease control Recruiting nowThis phase II trial tests how well propranolol and pembrolizumab work to cause tumor re-sensitization and therefore treatment in patients with triple negative breast cancer that has not responded to previous checkpoint inhibitor therapy (refractory), cannot be removed by surgery …
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New procedure aims to keep weight off after GLP-1 drugs are stopped
Disease control OngoingFractyl is evaluating Revita Duodenal Mucosal Resurfacing (DMR) in the REMAIN-1 pivotal study, which is designed to include two cohorts - an open label cohort referred to as REVEAL-1, and a randomized cohort, which includes both a midpoint analysis and a pivotal analysis. Patient…
Sponsor: Fractyl Health Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
A second chance for the heart: can rehab rewrite the story after shock?
Disease control Recruiting nowThis is a prospective and retrospective multicentre study conducted under the scientific coordination of the IRCCS Fondazione Don Gnocchi and funded by the Italian Ministry of Health (PNRR-MCNT2-2023-12377767). Using the Altshock registry, the largest multicentre Cardiogenic Shoc…
Sponsor: Fondazione Don Carlo Gnocchi ETS • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New antibody combo takes on Hard-to-Treat stomach cancers
Disease control OngoingThis study will investigate the safety, tolerability, and antitumor activity of S095029 (anti-NKG2A antibody) in combination with pembrolizumab in in microsatellite instability-high/Defective mismatch repair (MSI-H/dMMR) locally advanced unresectable or metastatic gastric /GEJ ad…
Phase 1/2 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for depression: quick switch to stronger meds may prevent chronic suffering
Symptom relief Recruiting nowOver 28 million people suffer from current depressive disorder in the European Union. Major depressive disorder (MDD) is one of the most common psychiatric illnesses. The symptoms cause clinically significant distress or impairment in social, occupational, and other important are…
Phase 3 • Sponsor: Dr. Inge Winter • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Teens who attempted suicide get digital lifeline in new study
Knowledge-focused Recruiting nowOur study is designed to study the efficacy of an Electronic based psycho-social intervention targeting healthy coping and problem solving skills to mitigate suicidal behaviour. This would integrate existing systems and bridge the gap in accessibility to care for suicidal behavio…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New drug combo aims to improve lymphoma treatment
Disease control OngoingThe purpose of this study is to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma (FL).
Phase 2 • Sponsor: Celgene • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Radioactive 'Smart Bomb' targets Hard-to-Treat prostate cancer in first human trial
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, therapeutic effect, and pharmacokinetics of \[225Ac\]Ac-FL-020 in participants with metastatic castration-resistant prostate cancer (mCRPC).
Phase 1 • Sponsor: Full-Life Technologies UK Limited • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New cocktail of drugs aims to shrink Hard-to-Treat throat cancer
Disease control Recruiting nowThe goal of this study is to learn the efficacy and safety of nimotuzumab combined with toripalimab and gemcitabine/cisplatin regimen treatment recurrent/distant-metastasis nasopharyngeal carcinoma.
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 26, 2026 19:08 UTC
-
New hope for lung cancer patients with a specific gene mutation
Disease control Recruiting nowThe researchers are doing this study to see if sotorasib is a safe and effective treatment for people with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation who have not received treatment for their cancer since it became advanced. (Participants have not recei…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC